CDK4/6 inhibitors — possible colitis: Ibrance, Kisqali (including the Kisqali Femara Co-Pack) and Verzenio. These pills are ...
Creams, sprays and washes that promise relief from genital herpes are easy to order online, but none of them has been ...
Remibrutinib is approved for chronic spontaneous urticaria (CSU) and most recently, symptomatic dermographism, with the label ...
Nogapendekin alfa inbakicept-pmln plus BCG now covers high-grade papillary-only disease, based on extrapolation from CIS ...
Following a bumpy regulatory road that involved a refusal-to-file, ImmunityBio has won FDA approval to expand Anktiva into ...
The Food and Drug Administration has taken a significant step that could reshape the ingredient lists of many everyday pantry ...
How About a Date? According to the FDA, Americans are throwing away about one-third of our food — roughly 20 pounds per ...
FDA expanded ANKTIVA plus BCG approval to all adult patients with BCG-unresponsive NMIBC, including papillary-only tumors, on October 14, 2026. This first-of-its-kind label for both CIS and ...
"This FDA approval is an important milestone for physicians treating patients with complex aortic aneurysms," said Jason ...
Coya is currently conducting the ALSTARS Trial, a Phase 2/3, randomized, multi-center, double-blind, placebo-controlled study to evaluate the efficacy and safety of COYA 302 for the treatment of ALS ...
Proposition 317 would direct state homeland security to target drug cartels. Voters will decide on the legislative referral ...
Elevar Therapeutics and Hengrui Pharma have resubmitted applications to the FDA seeking approval of rivoceranib plus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results